The ORP supports clinical trials by providing funding, resources, and infrastructure. It collaborates with NCCN Member Institutions to conduct Phase I, II, and III clinical trials, ensuring that new treatments are rigorously tested for efficacy and safety. The program also aids in the design and implementation of these trials, ensuring they meet the highest standards of scientific rigor.